Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.71 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.55 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.50 |
| ▸ | POLB | P06746 | 2/20 | 0.50 |
| ▸ | LMNA | P02545 | 1/20 | 0.50 |
| ▸ | CBX7 | O95931 | 2/20 | 0.49 |
| ▸ | CDYL2 | Q8N8U2 | 2/20 | 0.49 |
| ▸ | CDYL | Q9Y232 | 2/20 | 0.49 |
| ▸ | TP53 | P04637 | 2/20 | 0.49 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.49 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 1/20 | 0.49 |
| ▸ | HTT | P42858 | 1/20 | 0.48 |
| ▸ | USP2 | O75604 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | DRD4 | P21917 | 1/20 | 0.48 |
| ▸ | GRM5 | P41594 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13150794 | 0.80 | TSHR (0.66) | TSHRL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL7358743 | 0.79 | ALDH1A1 (0.61) | TSHRL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL8554427 | 0.79 | TSHR (0.64) | TSHRL3MBTL1KMT2AMEN1CHRM1 | |
| SCHEMBL31667554 | 0.77 | L3MBTL1 (0.70) | TSHRL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL474614 | 0.75 | TSHR (0.60) | TSHRL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL30808661 | 0.75 | KMT2A (0.68) | TSHRKMT2AMEN1ALDH1A1POLB | |
| SCHEMBL4970176 | 0.75 | KMT2A (0.68) | TSHRKMT2AMEN1ALDH1A1POLB | |
| SCHEMBL4886787 | 0.74 | PRMT5 (0.65) | TSHRL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL4506469 | 0.74 | ALDH1A1 (0.69) | TSHRL3MBTL1KMT2AMEN1ALDH1A1 | |
| SCHEMBL5346263 | 0.74 | PIK3CG (0.76) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7205295-B2 | Benzoxazin-3-ones and derivatives thereof as therapeutic agents | WARNER-LAMBERT COMPANY LLC (US) | 2007-04-17 | — | — | US | disclosed |
| EP-1569653-A1 | BENZOXAZIN-3-ONES AND DERIVATIVES THEREOF AS INHIBITORS OF PI3K | Warner-Lambert Company LLC (US) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004052373-A1 | BENZOXAZIN-3-ONES AND DERIVATIVES THEREOF AS INHIBITORS OF PI3K | WARNER-LAMBERT COMPANY LLC (US) | 2004-06-24 | — | — | WO | disclosed |
| US-20040121996-A1 | Benzoxazin-3-ones and derivatives thereof as therapeutic agents | BARVIAN NICOLE (US) | 2004-06-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040121996-A1 | Benzoxazin-3-ones and derivatives thereof as therapeutic agents | XDH, HAX1, CYP4X1 | TSHR 2417/4885L3MBTL1 3712/4885KMT2A 1548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.